Investment Status: Former

Adaptimmune is a biotechnology company developing cancer treatment with cell therapies.

RayzeBio is a biotechnology company pioneering radiopharmaceutical therapies for the treatment of cancer.

Atea is a biotechnology company developing oral antiviral therapies to address serious viral infections.

Tesaro is a biotechnology company developing cancer treatments.

Hua Medicine is a biotechnology company focused on innovative therapies for diabetes.

ImmunGene is a biotechnology company developing antibody-based therapies to treat cancer, autoimmune disorders, and other diseases.

Vifor is a biotechnology company developing iron deficiency and iron deficiency anaemia therapies.

Diffusion is a biotechnology company developing therapies to enhance the oxygen delivery to hypoxic tissues for the treatment of hypoxic solid tumors.

CARGO is a biotechnology company advancing CAR‑T cell therapies for cancers.

CG Oncology is a biotechnology company developing potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.